OA04796A - Procédé de préparation des thiényl phényl 0-(aminoalkyl)-cétone-oximes et furyl phényl 0-(aminoakyl)-cétone-oximes. - Google Patents

Procédé de préparation des thiényl phényl 0-(aminoalkyl)-cétone-oximes et furyl phényl 0-(aminoakyl)-cétone-oximes.

Info

Publication number
OA04796A
OA04796A OA55324A OA55324A OA04796A OA 04796 A OA04796 A OA 04796A OA 55324 A OA55324 A OA 55324A OA 55324 A OA55324 A OA 55324A OA 04796 A OA04796 A OA 04796A
Authority
OA
OAPI
Prior art keywords
oximes
ketone
phenyl
aminoakyl
aminoalkyl
Prior art date
Application number
OA55324A
Other languages
English (en)
French (fr)
Inventor
G Thuillier
J Laforest
P Bessin
Original Assignee
Cerpha
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cerpha filed Critical Cerpha
Publication of OA04796A publication Critical patent/OA04796A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/40—Radicals substituted by oxygen atoms
    • C07D307/46—Doubly bound oxygen atoms, or two oxygen atoms singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/70—Nitro radicals
    • C07D307/71—Nitro radicals attached in position 5
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22—Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/28—Halogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/42—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms
    • C07D333/44—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms with nitro or nitroso radicals directly attached to ring carbon atoms attached in position 5

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Furan Compounds (AREA)
OA55324A 1973-10-19 1974-10-16 Procédé de préparation des thiényl phényl 0-(aminoalkyl)-cétone-oximes et furyl phényl 0-(aminoakyl)-cétone-oximes. OA04796A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7337444A FR2248033B1 (xx) 1973-10-19 1973-10-19

Publications (1)

Publication Number Publication Date
OA04796A true OA04796A (fr) 1980-08-31

Family

ID=9126699

Family Applications (1)

Application Number Title Priority Date Filing Date
OA55324A OA04796A (fr) 1973-10-19 1974-10-16 Procédé de préparation des thiényl phényl 0-(aminoalkyl)-cétone-oximes et furyl phényl 0-(aminoakyl)-cétone-oximes.

Country Status (19)

Country Link
US (1) US4029808A (xx)
JP (3) JPS50111064A (xx)
AT (1) AT339890B (xx)
BE (1) BE821237A (xx)
CA (1) CA1064491A (xx)
CH (1) CH601279A5 (xx)
CS (1) CS192537B2 (xx)
DD (1) DD115118A5 (xx)
DE (2) DE2463088C1 (xx)
FR (1) FR2248033B1 (xx)
GB (1) GB1436307A (xx)
HU (1) HU170388B (xx)
IL (1) IL45772A (xx)
NL (1) NL7412659A (xx)
OA (1) OA04796A (xx)
PH (1) PH12992A (xx)
PL (1) PL99875B1 (xx)
YU (1) YU36514B (xx)
ZA (1) ZA746631B (xx)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4207319A (en) * 1973-10-19 1980-06-10 Albert Rolland S.A. Thienyl or furyl phenyl O-hetero amino alkyl oximes and use thereof
US4148911A (en) * 1977-07-08 1979-04-10 Societe Anonyme Dite Albert Rolland S.A. Method of treating respiratory disorders
FR2428036A1 (fr) * 1978-06-08 1980-01-04 Rolland Sa A Nouveaux intermediaires de synthese pour la preparation de 0-(amino alkyl) oximes diaromatiques
US4246277A (en) * 1979-06-22 1981-01-20 Albert Rolland S.A. Lowering the concentration of plasma triglycerides
FR2480752A1 (fr) * 1980-04-21 1981-10-23 Cherqui Jean Nouveaux composes derives de la phenylthiazolylcetone, leur procede d'obtention et les compositions pharmaceutiques en contenant
JPS56174550U (xx) * 1980-05-27 1981-12-23
DK270488D0 (da) * 1988-05-18 1988-05-18 Novo Industri As Hidtil ukendte o-substituerede ketoximer
CN1094487C (zh) * 1994-04-01 2002-11-20 盐野义制药株式会社 肟衍生物和含有其作为活性成分的杀菌剂
US6268312B1 (en) * 1994-04-01 2001-07-31 Shionogi & Co., Ltd. Oxime derivative and bactericide containing the same as active ingredient

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3084171A (en) * 1961-10-19 1963-04-02 Abbott Lab 5-nitro-2-furylamidine and alkyl 5-nitro-2-furylimidate
US3272833A (en) * 1963-10-09 1966-09-13 Abbott Lab Certain substituted 5-nitro-2-furylamidoximes
NL6810133A (xx) * 1968-07-18 1970-01-20
US3895039A (en) * 1972-11-06 1975-07-15 Roussel Uclaf Carbamaldoximes

Also Published As

Publication number Publication date
BE821237A (fr) 1975-02-17
YU36514B (en) 1984-02-29
CA1064491A (en) 1979-10-16
IL45772A (en) 1978-04-30
DD115118A5 (xx) 1975-09-12
US4029808A (en) 1977-06-14
HU170388B (xx) 1977-06-28
AU7415574A (en) 1976-04-15
ZA746631B (en) 1976-02-25
PL99875B1 (pl) 1978-08-31
CH601279A5 (xx) 1978-06-30
JPS5538946B2 (xx) 1980-10-07
PH12992A (en) 1979-10-29
AT339890B (de) 1977-11-10
JPS50111064A (en) 1975-09-01
ATA829274A (de) 1977-03-15
FR2248033B1 (xx) 1977-03-11
DE2463088C1 (de) 1982-07-15
GB1436307A (en) 1976-05-19
YU277774A (en) 1982-02-25
JPS5373556A (en) 1978-06-30
JPS5325555A (en) 1978-03-09
IL45772A0 (en) 1974-12-31
DE2449205A1 (de) 1975-04-24
CS192537B2 (en) 1979-08-31
NL7412659A (nl) 1975-04-22
DE2449205C2 (de) 1982-03-11
FR2248033A1 (xx) 1975-05-16

Similar Documents

Publication Publication Date Title
SE7503307L (sv) Forfarande for behandling av organiska avfallsprodukter.
OA04868A (fr) Dérivés de 2-acyl-4-oxo-pyrazino-isoquinoléine et leur procédé de préparation.
SE411099B (sv) Apparat for befremjande av lekningsprocesser
OA04704A (fr) Procédé de préparation de nouveaux vaccins.
FR2281788A1 (fr) Compositions ameliorees pour catalyse et leur procede de preparation
OA05577A (fr) Procédé de préparation de compositions pharmaceutiques renfermant des pyréthrinoïdes.
SE417107B (sv) Forfarande for foredling av sapor
OA05022A (fr) Procédé de préparation de nouveaux dérivés de benzothiophène.
NO741886L (no) Fremgangsmåte for fremstilling av et veterinærpreparat.
BE814867A (fr) Procede de preparation de 1-carbamyl-amino-acides et des 1-aminoacides correspondants
BE834064A (fr) Procede de preparation de carboxamides de oxo-1,2-benzothiazine-1, 1-dioxydes
BE828430A (fr) Phenylalcoylamines, leur procede d'obtention et leur application commemedicaments
OA04511A (fr) Procédé de préparation de 3-hydroxycéphalosporines.
OA04809A (fr) Procédé de préparation d'a-aminoacyl-3-halocépha-losporines.
OA04418A (fr) Germes artificielles et leur procédé de préparation.
NO741223L (no) Fremgangsmåte for fremstilling av 6-deoksytetracykliner.
SE7506293L (sv) Farmaceutiska kompositioner for behandling av hyperkolesterolemi.
BE833655A (fr) Procede de production de carboxamides de oxo-1,2-benzothiazine-1,1-dioxydes
CH514543A (fr) Procédé de préparation de nouveaux 5,8-dihydroxynaphtyloxyamino-propanols
SE401363B (sv) Forfarande for behandling av en avlut enligt en aktivslammetod
OA04771A (fr) Nouveaux 2, 3-dihydrobenzofuranyl-7-N-méthylcarbamates N-sulfénylés, leur procédé de préparation et leur application comme insecticide.
NO741133L (no) Fremgangsmåte for fremstilling av metyl-3-(2-kinoksalinylmetylen)-karbazat-N1.N4-dioksyd.
BE809681A (fr) Procede de preparation de polyesters cycliques
FI55836C (fi) Foerfarande foer framstaellning av terapeutiskt verksamma 4-amino-3-benzylidenhydrazino-1,2,4-triazoler
BE817169A (fr) Phosphates organiques